- Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis
-
Kim TW, Kim WK, Lee JH, Kim SB, Kim SW, Suh C, Lee KH, Lee JS, Seo EJ, Chi HS, Kim SH
- KMID: 1038437
- J Korean Med Sci.
- 1998 Dec;13(6):587-590.
- doi: 10.3346/jkms.1998.13.6.587
Activated protein C (APC) is a naturally occurring anticoagulant that interacts with factor V and VIII to inhibit the clotting cascade. The prevalence of APC resistance among Korean patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Deep Vein Thrombosis in the Lower Extremities in Comatose Elderly Patients with Acute Neurological Diseases
-
Yamada SM, Tomita Y, Murakami H, Nakane M
- KMID: 2374044
- Yonsei Med J.
- 2016 Mar;57(2):388-392.
- doi: 10.3349/ymj.2016.57.2.388
PURPOSE: Comatose elderly patients with acute neurological illness have a great risk of deep vein thrombosis (DVT). In this study, the incidence of DVT and the effectiveness of early initiation... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and Clinical Associations of Lupus Anticoagulant, Anticardiolipin Antibodies, and Anti-beta2-glycoprotein I Antibodies in Patients with Systemic Lupus Erythematosus
-
Woo KS, Kim KE, Kim JM, Han JY, Chung WT, Kim KH
- KMID: 1096817
- Korean J Lab Med.
- 2010 Feb;30(1):38-44.
- doi: 10.3343/kjlm.2010.30.1.38
BACKGROUND: The presence of antiphospholipid antibodies (aPLs) is associated with the clinical features of antiphospholipid syndrome (APS), which comprises venous and arterial thrombosis and pregnancy loss, and systemic lupus erythematosus... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Effectiveness of Central Venous Catheterization in Patients with Cancer: Prospective Observational Study
-
Kim HJ, Yun J, Kim HJ, Kim KH, Kim SH, Lee SC, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Park HS, Hong DS
- KMID: 1792898
- J Korean Med Sci.
- 2010 Dec;25(12):1748-1753.
- doi: 10.3346/jkms.2010.25.12.1748
This study investigated the safety and effectiveness of each type of central venous catheters (CVC) in patients with cancer. We prospectively enrolled patients with cancer who underwent catherization involving a... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-Heparin-Platelet Factor 4 Antibody is a Risk Factor for Vascular Access Obstruction in Patients Undergoing Hemodialysis
-
Lee EY, Hwang KY, Yang JO, Hong SY
- KMID: 1099796
- J Korean Med Sci.
- 2003 Feb;18(1):69-72.
- doi: 10.3346/jkms.2003.18.1.69
Since heparin is an anticoagulant commonly used in hemodialysis and the patients on hemodialysis are repeatedly exposed to heparin, heparin may be the cause of the development of heparin-dependent antibodies... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials
-
Park J, Lee JM, Lee JS, Cho YJ
- KMID: 2470282
- J Korean Med Sci.
- 2016 Nov;31(11):1828-1837.
- doi: 10.3346/jkms.2016.31.11.1828
Thromboprophylaxis for venous thromboembolism is widely used in critically ill patients. However, only limited evidence exists regarding the efficacy and safety of the various thromboprophylaxis techniques, especially mechanical thromboprophylaxis. Therefore,... -
- CITED
-
- Close
- SHARE
-
- Close
- Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians
-
Oh D, Kim S, Lim CY, Lee JS, Park S, Garcia D, Crowther M, Ageno W
- KMID: 2158114
- Yonsei Med J.
- 2005 Feb;46(1):66-72.
- doi: 10.3349/ymj.2005.46.1.66
The optimal perioperative anticoagulation management in patients on warfarin therapy is poorly defined due to the lack of randomized trials. Because guidelines are heterogeneous, it was hypothesized that "treatment strategies... -
- CITED
-
- Close
- SHARE
-
- Close
